Suppression of human immunodeficiency virus type-1 production by coexpression of catalytic-region-deleted N-myristoyltransferase mutants

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 12, 2010, Pages 2018-2023

  Takamune, Nobutoki ^a   Kuroe, Tetsuya ^a   Tanada, Noriaki ^a   Shoji, Shozo ^a,b   Misumi, Shogo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO HEALTH SCIENCE UNIVERSITY   (Japan)

Author keywords

Human immunodeficiency virus type 1; N myristoylation; N myristoyltransferase; Nef; Pr55gag; Ribosome

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; ISOENZYME; N MYRISTOYLTRANSFERASE 1; N MYRISTOYLTRANSFERASE 2; NEF PROTEIN; PR55GAG PROTEIN; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; EMBRYO; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME SPECIFICITY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MYRISTYLATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RIBOSOME; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ACYLTRANSFERASES; CATALYTIC DOMAIN; HIV-1; HUMANS; ISOENZYMES; MUTATION; RIBOSOMES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 78751511233     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.2018     Document Type: Article

References (24)

1. Towler D. A., Adams S. P., Eubanks S. R., Towery D. S., Jackson- Machelski E., Glaser L., Gordon J. I., J. Biol. Chem., 263, 1784-1790 (1988).
2. Carr S. A., Biemann K., Shoji S., Parmelee D. C., Titani K., Proc. Natl. Acad. Sci. U.S.A., 79, 6128-6131 (1982).
3. Towler D., Glaser L., Proc. Natl. Acad. Sci. U.S.A., 83, 2812-2816 (1986).
4. Wilcox C., Hu J. S., Olson E. N., Science, 238, 1275-1278 (1987).
5. Zha J., Weiler S., Oh K. J., Wei M. C., Korsmeyer S. J., Science, 290, 1761-1765 (2000).
6. Boutin J. A., Cell Signal., 9, 15-35 (1997).
7. Resh M. D., Biochim. Biophys. Acta, 1451, 1-16 (1999).
8. Bryant M., Ratner L., Proc. Natl. Acad. Sci. U.S.A., 87, 523-527 (1990).
9. Guy B., Kieny M. P., Riviere Y., Le Peuch C., Dott K., Girard M., Montagnier L., Lecocq J. P., Nature (London), 330, 266-269 (1987).
10. Fackler O. T., Moris A., Tibroni N., Giese S. I., Glass B., Schwartz O., Krausslich H. G., Virology, 351, 322-339 (2006).
11. Duronio R. J., Reed S. I., Gordon J. I., Proc. Natl. Acad. Sci. U.S.A., 89, 4129-4133 (1992).
12. Giang D. K., Cravatt B. F., J. Biol. Chem., 273, 6595-6598 (1998).
13. McIlhinney R. A., Young K., Egerton M., Camble R., White A., Soloviev M., Biochem. J., 333, 491-495 (1998).
14. Yang S. H., Shrivastav A., Kosinski C., Sharma R. K., Chen M. H., Berthiaume L. G., Peters L. L., Chuang P. T., Young S. G., Bergo M. O., J. Biol. Chem., 280, 18990-18995 (2005).
15. Ducker C. E., Upson J. J., French K. J., Smith C. D., Mol. Cancer Res., 3, 463-476 (2005).
16. Takamune N., Gota K., Misumi S., Tanaka K., Okinaka S., Shoji S., Microbes. Infect., 10, 143-150 (2008).
17. Seaton K. E., Smith C. D., J. Gen. Virol., 89, 288-296 (2008).
18. Glover C. J., Hartman K. D., Felsted R. L., J. Biol. Chem., 272, 28680-28689 (1997).
19. Lee S. K., Harris J., Swanstrom R., J. Virol., 83, 8536-8543 (2009).
20. Maurer-Stroh S., Eisenhaber B., Eisenhaber F., J. Mol. Biol., 317, 523-540 (2002).
21. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J., Richman D. D., Guatelli J. C., J. Virol., 68, 2906-2914 (1994).
22. Flexner C., Nat. Rev. Drug Discov., 6, 959-966 (2007).
23. Cohen J., Science, 319, 143-144 (2008).
24. Maurer-Stroh S., Eisenhaber B., Eisenhaber F., J. Mol. Biol., 317, 541-557 (2002).